PRCT · Categories · Downgrades
PRCT - Analyst downgrades
PROCEPT BioRobotics Corporation (PRCT) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for PRCT
- PROCEPT BioRobotics downgraded by William BlairWilliam Blair downgraded PROCEPT BioRobotics from Outperform to Mkt Perform
- PROCEPT BioRobotics downgraded by Wells Fargo with a new price targetWells Fargo downgraded PROCEPT BioRobotics from Overweight to Equal Weight and set a new price target of $19.00
- PROCEPT BioRobotics downgraded by UBS with a new price targetUBS downgraded PROCEPT BioRobotics from Buy to Neutral and set a new price target of $20.00
- PROCEPT BioRobotics downgraded by Truist with a new price targetTruist downgraded PROCEPT BioRobotics from Buy to Hold and set a new price target of $25.00
- PROCEPT BioRobotics downgraded by Leerink Partners with a new price targetLeerink Partners downgraded PROCEPT BioRobotics from Outperform to Market Perform and set a new price target of $29.00
- PROCEPT BioRobotics downgraded by OppenheimerOppenheimer downgraded PROCEPT BioRobotics from Outperform to Perform
- PROCEPT BioRobotics downgraded by BofA Securities with a new price targetBofA Securities downgraded PROCEPT BioRobotics from Neutral to Underperform and set a new price target of $20.00
- PROCEPT BioRobotics downgraded by BofA Securities with a new price targetBofA Securities downgraded PROCEPT BioRobotics from Buy to Neutral and set a new price target of $38.00